{"entity":{"type":"insider","cik":"0001259780","url":"/insider/0001259780","json_url":"/insider/0001259780.json","name":"KIES PETER","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":14,"first":"2004-09-15","last":"2021-06-11","span_basis":"filed_date"},"name_variants":[{"name":"KIES PETER","source":"filing","n_filings":14,"first_seen":"2004-09-15","last_seen":"2021-06-11"}],"transactions":[{"id":4608005,"accession":"0001055726-21-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001055726-21-000050","line_url":"/filing/0001055726-21-000050#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33750.0,"shares_display":"33,750","price_per_share":10.01,"price_display":"10.01","price_state":"stated","total_value":337837.5,"total_display":"337,837.50","total_whole":"337,838","shares_owned_after":130788.0,"shares_owned_after_display":"130,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-11","scope":"insider"},{"id":4455645,"accession":"0001055726-21-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001055726-21-000049","line_url":"/filing/0001055726-21-000049#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":8.03,"price_display":"8.03","price_state":"stated","total_value":80300.0,"total_display":"80,300.00","total_whole":"80,300","shares_owned_after":150788.0,"shares_owned_after_display":"150,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-03","filed_date":"2021-06-04","scope":"insider"},{"id":4607991,"accession":"0001055726-21-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001055726-21-000037","line_url":"/filing/0001055726-21-000037#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":8.52,"price_display":"8.52","price_state":"stated","total_value":85200.0,"total_display":"85,200.00","total_whole":"85,200","shares_owned_after":160788.0,"shares_owned_after_display":"160,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-21","filed_date":"2021-04-21","scope":"insider"},{"id":4166737,"accession":"0001055726-21-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001055726-21-000004","line_url":"/filing/0001055726-21-000004#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":10.0186,"price_display":"10.02","price_state":"stated","total_value":300558.0,"total_display":"300,558.00","total_whole":"300,558","shares_owned_after":119290.0,"shares_owned_after_display":"119,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-15","scope":"insider"},{"id":2422883,"accession":"0001055726-20-000056","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001055726-20-000056","line_url":"/filing/0001055726-20-000056#line-3","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":10.6853,"price_display":"10.69","price_state":"stated","total_value":213706.0,"total_display":"213,706.00","total_whole":"213,706","shares_owned_after":119290.0,"shares_owned_after_display":"119,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-17","scope":"insider"},{"id":2516110,"accession":"0001055726-20-000044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001055726-20-000044","line_url":"/filing/0001055726-20-000044#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":24.9488,"price_display":"24.95","price_state":"stated","total_value":873208.0,"total_display":"873,208.00","total_whole":"873,208","shares_owned_after":119290.0,"shares_owned_after_display":"119,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-15","filed_date":"2020-07-17","scope":"insider"},{"id":2861274,"accession":"0001055726-20-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001055726-20-000043","line_url":"/filing/0001055726-20-000043#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":26.5,"price_display":"26.50","price_state":"stated","total_value":927500.0,"total_display":"927,500.00","total_whole":"927,500","shares_owned_after":119290.0,"shares_owned_after_display":"119,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-30","filed_date":"2020-07-02","scope":"insider"},{"id":6220118,"accession":"0001055726-18-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001055726-18-000047","line_url":"/filing/0001055726-18-000047#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10001.0,"shares_display":"10,001","price_per_share":5.28,"price_display":"5.28","price_state":"stated","total_value":52805.28,"total_display":"52,805.28","total_whole":"52,805","shares_owned_after":62088.0,"shares_owned_after_display":"62,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-29","filed_date":"2018-11-30","scope":"insider"},{"id":5957820,"accession":"0001055726-18-000037","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001055726-18-000037","line_url":"/filing/0001055726-18-000037#line-3","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":4.45,"price_display":"4.45","price_state":"stated","total_value":44500.0,"total_display":"44,500.00","total_whole":"44,500","shares_owned_after":62088.0,"shares_owned_after_display":"62,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-10","filed_date":"2018-07-11","scope":"insider"},{"id":5957818,"accession":"0001055726-18-000037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001055726-18-000037","line_url":"/filing/0001055726-18-000037#line-2","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":4.43,"price_display":"4.43","price_state":"stated","total_value":110750.0,"total_display":"110,750.00","total_whole":"110,750","shares_owned_after":72088.0,"shares_owned_after_display":"72,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-09","filed_date":"2018-07-11","scope":"insider"},{"id":6748484,"accession":"0001179110-14-015306","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-015306","line_url":"/filing/0001179110-14-015306#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3960.0,"shares_display":"3,960","price_per_share":10.1,"price_display":"10.10","price_state":"stated","total_value":39996.0,"total_display":"39,996.00","total_whole":"39,996","shares_owned_after":21388.0,"shares_owned_after_display":"21,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-09","filed_date":"2014-10-09","scope":"insider"},{"id":2189209,"accession":"0001179110-12-009606","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-009606","line_url":"/filing/0001179110-12-009606#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.41,"price_display":"0.41","price_state":"stated","total_value":10250.0,"total_display":"10,250.00","total_whole":"10,250","shares_owned_after":69712.0,"shares_owned_after_display":"69,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-05","filed_date":"2012-06-05","scope":"insider"},{"id":8992177,"accession":"0001179110-11-014062","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-11-014062","line_url":"/filing/0001179110-11-014062#line-3","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18000.0,"shares_display":"18,000","price_per_share":0.535,"price_display":"0.54","price_state":"stated","total_value":9630.0,"total_display":"9,630.00","total_whole":"9,630","shares_owned_after":18000.0,"shares_owned_after_display":"18,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-10-05","filed_date":"2011-10-05","scope":"insider"},{"id":8992176,"accession":"0001179110-11-014062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-11-014062","line_url":"/filing/0001179110-11-014062","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19150.0,"shares_display":"19,150","price_per_share":0.501514360313316,"price_display":"0.50","price_state":"stated","total_value":9604.0,"total_display":"9,604.00","total_whole":"9,604","shares_owned_after":44712.0,"shares_owned_after_display":"44,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-04","filed_date":"2011-10-05","scope":"insider","n_lines":2},{"id":9014197,"accession":"0001179110-11-010082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-010082","line_url":"/filing/0001179110-11-010082#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"INOVIO PHARMACEUTICALS, INC.","issuer_ticker":"INO","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24000.0,"shares_display":"24,000","price_per_share":0.5676,"price_display":"0.57","price_state":"stated","total_value":13622.4,"total_display":"13,622.40","total_whole":"13,622","shares_owned_after":25562.0,"shares_owned_after_display":"25,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-24","filed_date":"2011-06-24","scope":"insider"},{"id":231001,"accession":"0001179110-04-018111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-04-018111","line_url":"/filing/0001179110-04-018111#line-1","is_derivative":false,"issuer_cik":"0001055726","issuer_name":"GENETRONICS BIOMEDICAL CORP","issuer_ticker":"GEB","issuer_name_source":null,"issuer_url":"/issuer/0001055726","owner_cik":"0001259780","owner_name":"KIES PETER","owner_display_name":"KIES PETER","owner_url":"/insider/0001259780","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Genetronics Biomedical Series C Convertible Preferred Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1.0,"shares_display":"1","price_per_share":5882.35,"price_display":"5,882.35","price_state":"stated","total_value":5882.35,"total_display":"5,882.35","total_whole":"5,882","shares_owned_after":1.0,"shares_owned_after_display":"1","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-09-14","filed_date":"2004-09-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001055726","name":"INOVIO PHARMACEUTICALS, INC.","url":"/issuer/0001055726","role":"Officer (CFO)","n_filings":14,"first_seen":"2004-09-15","last_seen":"2021-06-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001259780","retrieved_at":"2026-08-25T17:55:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}